Synergistic Removal of Static and Dynamic Staphylococcus aureus Biofilms by Combined Treatment with a Bacteriophage Endolysin and a Polysaccharide Depolymerase.
Nanna M C OlsenElowine ThiranTobias HaslerThomas VanzieleghemGeorgios N BelibasakisJacques MahillonMartin J LoessnerMathias SchmelcherPublished in: Viruses (2018)
Staphylococcus aureus is an important pathogen and biofilm former. Biofilms cause problems in clinics and food production and are highly recalcitrant to antibiotics and sanitizers. Bacteriophage endolysins kill bacteria by degrading their cell wall and are therefore deemed promising antimicrobials and anti-biofilm agents. Depolymerases targeting polysaccharides in the extracellular matrix have been suggested as parts of a multi-enzyme approach to eradicate biofilms. The efficacy of endolysins and depolymerases against S. aureus biofilms in static models has been demonstrated. However, there is a lack of studies evaluating their activity against biofilms grown under more realistic conditions. Here, we investigated the efficacy of the endolysin LysK and the poly-N-acetylglucosamine depolymerase DA7 against staphylococcal biofilms in static and dynamic (flow cell-based) models. LysK showed activity against multiple S. aureus strains, and both LysK and DA7 removed static and dynamic biofilms from polystyrene and glass surfaces at low micromolar and nanomolar concentrations, respectively. When combined, the enzymes acted synergistically, as demonstrated by crystal violet staining of static biofilms, significantly reducing viable cell counts compared to individual enzyme treatment in the dynamic model, and confocal laser scanning microscopy. Overall, our results suggest that LysK and DA7 are potent anti-biofilm agents, alone and in combination.
Keyphrases
- candida albicans
- staphylococcus aureus
- biofilm formation
- extracellular matrix
- pseudomonas aeruginosa
- single cell
- cell wall
- escherichia coli
- high resolution
- mental health
- high speed
- stem cells
- cell therapy
- combination therapy
- high throughput
- climate change
- single molecule
- risk assessment
- peripheral blood
- drug delivery
- methicillin resistant staphylococcus aureus
- anti inflammatory
- mesenchymal stem cells
- bone marrow
- smoking cessation
- case control
- human health